Composite Biomarker Predicts Cardiovascular-Kidney-Metabolic Syndrome Progression
Researchers have identified a novel composite biomarker, the triglyceride-glucose-normalized creatinine-to-cystatin C ratio (TyG-NCCR), that predicts the progression of cardiovascular-kidney-metabolic (CKM) ...

